Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • @Ensign_Crab
    link
    English
    251 year ago

    We need to shorten the term for patents and make patent extension more difficult for this reason alone.